AI-generated summary
The authors studied whether low-level laser therapy could reduce low salivary flow in head and neck cancer patients receiving radiochemotherapy, comparing 17 treated patients with 10 receiving clinical care only. They report significantly higher salivary flow rates in the laser group at several time points during and shortly after treatment. The authors conclude that low-level laser seems to be an efficient tool for mitigating salivary hypofunction.
- Who or what was studied
- Patients with head and neck cancer undergoing radiochemotherapy (17 received laser therapy, 10 received clinical care only)
- Wavelengths
- 660, 780 nm
- Limits stated in the abstract
- The abstract reports a small, non-randomized comparison group and does not describe randomization or blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 780 nm
- Power
- 40 mW, 15 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.